|
[1]
|
Bray, F., Laversanne, M., Weiderpass, E. and Soerjomataram, I. (2021) The Ever‐Increasing Importance of Cancer as a Leading Cause of Premature Death Worldwide. Cancer, 127, 3029-3030. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Gadgeel, S., Rodríguez-Abreu, D., Speranza, G., Esteban, E., Felip, E., Dómine, M., et al. (2020) Updated Analysis from KEYNOTE-189: Pembrolizumab or Placebo plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer. Journal of Clinical Oncology, 38, 1505-1517. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Mok, T.S.K., Wu, Y., Kudaba, I., Kowalski, D.M., Cho, B.C., Turna, H.Z., et al. (2019) Pembrolizumab versus Chemotherapy for Previously Untreated, Pd-L1-Expressing, Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (KEYNOTE-042): A Randomised, Open-Label, Controlled, Phase 3 Trial. The Lancet, 393, 1819-1830. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Paz-Ares, L., Vicente, D., Tafreshi, A., Robinson, A., Soto Parra, H., Mazières, J., et al. (2020) A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients with Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of Keynote-407. Journal of Thoracic Oncology, 15, 1657-1669. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Chen, D.S. and Mellman, I. (2013) Oncology Meets Immunology: The Cancer-Immunity Cycle. Immunity, 39, 1-10. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Garcia‐Lora, A., Algarra, I. and Garrido, F. (2003) MHC Class I Antigens, Immune Surveillance, and Tumor Immune Escape. Journal of Cellular Physiology, 195, 346-355. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Labani-Motlagh, A., Ashja-Mahdavi, M. and Loskog, A. (2020) The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses. Frontiers in Immunology, 11, Article No. 940. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
De Jaeghere, E.A., Denys, H.G. and De Wever, O. (2019) Fibroblasts Fuel Immune Escape in the Tumor Microenvironment. Trends in Cancer, 5, 704-723. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Jiang, X., Wang, J., Deng, X., Xiong, F., Ge, J., Xiang, B., et al. (2019) Role of the Tumor Microenvironment in PD-L1/PD-1-Mediated Tumor Immune Escape. Molecular Cancer, 18, Article No. 10. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Formenti, S.C. and Demaria, S. (2012) Radiation Therapy to Convert the Tumor into an in Situ Vaccine. International Journal of Radiation Oncology Biology Physics, 84, 879-880. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Herrera, F.G., Ronet, C., Ochoa de Olza, M., Barras, D., Crespo, I., Andreatta, M., et al. (2022) Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy. Cancer Discovery, 12, 108-133. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Mavragani, I.V., Laskaratou, D.A., Frey, B., Candéias, S.M., Gaipl, U.S., Lumniczky, K., et al. (2015) Key Mechanisms Involved in Ionizing Radiation-Induced Systemic Effects. A Current Review. Toxicology Research, 5, 12-33. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Mavragani, I., Nikitaki, Z., Souli, M., Aziz, A., Nowsheen, S., Aziz, K., et al. (2017) Complex DNA Damage: A Route to Radiation-Induced Genomic Instability and Carcinogenesis. Cancers, 9, Article No. 91. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Heil, M. and Land, W.G. (2014) Danger Signals—Damaged-Self Recognition across the Tree of Life. Frontiers in Plant Science, 5, Article No. 578. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Dovedi, S.J., Cheadle, E.J., Popple, A.L., Poon, E., Morrow, M., Stewart, R., et al. (2017) Fractionated Radiation Therapy Stimulates Antitumor Immunity Mediated by Both Resident and Infiltrating Polyclonal T-Cell Populations When Combined with PD-1 Blockade. Clinical Cancer Research, 23, 5514-5526. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Lussier, D.M., Alspach, E., Ward, J.P., Miceli, A.P., Runci, D., White, J.M., et al. (2021) Radiation-Induced Neoantigens Broaden the Immunotherapeutic Window of Cancers with Low Mutational Loads. Proceedings of the National Academy of Sciences, 118, e2102611118. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Wang, Y., Xiang, Y., Xin, V.W., Wang, X., Peng, X., Liu, X., et al. (2020) Dendritic Cell Biology and Its Role in Tumor Immunotherapy. Journal of Hematology & Oncology, 13, Article No. 107. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Marciscano, A.E. and Anandasabapathy, N. (2021) The Role of Dendritic Cells in Cancer and Anti-Tumor Immunity. Seminars in Immunology, 52, Article ID: 101481. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Le Gall, C.M., Weiden, J., Eggermont, L.J. and Figdor, C.G. (2018) Dendritic Cells in Cancer Immunotherapy. Nature Materials, 17, 474-475. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Alloatti, A., Kotsias, F., Magalhaes, J.G. and Amigorena, S. (2016) Dendritic Cell Maturation and Cross‐Presentation: Timing Matters! Immunological Reviews, 272, 97-108. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Villadangos, J.A. and Schnorrer, P. (2007) Intrinsic and Cooperative Antigen-Presenting Functions of Dendritic-Cell Subsets in Vivo. Nature Reviews Immunology, 7, 543-555. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Chun, S.H., Park, G., Han, Y.K., Kim, S.D., Kim, J.S., Lee, C.G., et al. (2013) Effect of Low Dose Radiation on Differentiation of Bone Marrow Cells into Dendritic Cells. Dose-Response, 11, 12-41. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Lumniczky, K., Impens, N., Armengol, G., Candéias, S., Georgakilas, A.G., Hornhardt, S., et al. (2021) Low Dose Ionizing Radiation Effects on the Immune System. Environment International, 149, Article ID: 106212. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Wang, S., Yu, H., He, R., Song, X., Chen, S., Yu, N., et al. (2019) Exposure to Low-Dose Radiation Enhanced the Antitumor Effect of a Dendritic Cell Vaccine. Dose-Response, 17, Article ID: 500665362. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Shigematsu, A., Adachi, Y., Koike-Kiriyama, N., Suzuki, Y., Iwasaki, M., Koike, Y., et al. (2007) Effects of Low-Dose Irradiation on Enhancement of Immunity by Dendritic Cells. Journal of Radiation Research, 48, 51-55. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Shastri, N., Cardinaud, S., Schwab, S.R., Serwold, T. and Kunisawa, J. (2005) All the Peptides That Fit: The Beginning, the Middle, and the End of the MHC Class I Antigen‐Processing Pathway. Immunological Reviews, 207, 31-41. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Lee, M.Y., Jeon, J.W., Sievers, C. and Allen, C.T. (2020) Antigen Processing and Presentation in Cancer Immunotherapy. Journal for ImmunoTherapy of Cancer, 8, e001111. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Axelrod, M.L., Cook, R.S., Johnson, D.B. and Balko, J.M. (2019) Biological Consequences of MHC-II Expression by Tumor Cells in Cancer. Clinical Cancer Research, 25, 2392-2402. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Reits, E.A., Hodge, J.W., Herberts, C.A., Groothuis, T.A., Chakraborty, M., K.Wansley, E., et al. (2006) Radiation Modulates the Peptide Repertoire, Enhances MHC Class I Expression, and Induces Successful Antitumor Immunotherapy. The Journal of Experimental Medicine, 203, 1259-1271. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Liu, C., Suksanpaisan, L., Chen, Y., Russell, S.J. and Peng, K. (2013) Enhancing Cytokine-Induced Killer Cell Therapy of Multiple Myeloma. Experimental Hematology, 41, 508-517. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Raulet, D.H. and Vance, R.E. (2006) Self-Tolerance of Natural Killer Cells. Nature Reviews Immunology, 6, 520-531. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Liu, S., Jin, S., Liu, X. and Sun, Y. (2001) Role of CD28/B7 Costimulation and IL-12/IL-10 Interaction in the Radiation-Induced Immune Changes. BMC Immunology, 2, Article No. 8. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Liu, S. (2003) Nonlinear Dose-Response Relationship in the Immune System Following Exposure to Ionizing Radiation: Mechanisms and Implications. Nonlinearity in Biology, Toxicology, Medicine, 1, Article ID: 971641180. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Carmona-Rodríguez, L., Martínez-Rey, D., Mira, E. and Mañes, S. (2020) SOD3 Boosts T Cell Infiltration by Normalizing the Tumor Endothelium and Inducing Laminin-α4. OncoImmunology, 9, Article ID: 1794163. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Griffioen, A., Damen, C., Martinotti, S., et al. (1996) Endothelial Intercellular Adhesion Molecule-1 Expression Is Suppressed in Human Malignancies: The Role of Angiogenic Factors. Cancer Research, 56, 1111-1117.
|
|
[36]
|
Barsoumian, H.B., Ramapriyan, R., Younes, A.I., Caetano, M.S., Menon, H., Comeaux, N.I., et al. (2020) Low-Dose Radiation Treatment Enhances Systemic Antitumor Immune Responses by Overcoming the Inhibitory Stroma. Journal for ImmunoTherapy of Cancer, 8, e000537. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Zhou, L., Zhang, X., Li, H., Niu, C., Yu, D., Yang, G., et al. (2018) Validating the Pivotal Role of the Immune System in Low‐Dose Radiation‐Induced Tumor Inhibition in Lewis Lung Cancer‐Bearing Mice. Cancer Medicine, 7, 1338-1348. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Yin, L., Xue, J., Li, R., Zhou, L., Deng, L., Chen, L., et al. (2020) Effect of Low-Dose Radiation Therapy on Abscopal Responses to Hypofractionated Radiation Therapy and Anti-PD1 in Mice and Patients with Non-Small Cell Lung Cancer. International Journal of Radiation Oncology Biology Physics, 108, 212-224. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Du, J., Su, S., Li, H., Shao, J., Meng, F., Yang, M., et al. (2017) Low Dose Irradiation Increases Adoptive Cytotoxic T Lymphocyte Migration in Gastric Cancer. Experimental and Therapeutic Medicine, 14, 5711-5716. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Farooque, A., Mathur, R., Verma, A., Kaul, V., Bhatt, A.N., Adhikari, J.S., et al. (2011) Low-Dose Radiation Therapy of Cancer: Role of Immune Enhancement. Expert Review of Anticancer Therapy, 11, 791-802. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Kumari, A., Cacan, E., Greer, S.F. and Garnett-Benson, C. (2013) Turning T Cells on: Epigenetically Enhanced Expression of Effector T-Cell Costimulatory Molecules on Irradiated Human Tumor Cells. Journal for ImmunoTherapy of Cancer, 1, Article No. 17. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Tu, T.H., Kim, C., Nam‐Goong, I.S., Nam, C.W., Kim, Y., Goto, T., et al. (2015) 4‐1BBL Signaling Promotes Cell Proliferation through Reprogramming of Glucose Metabolism in Monocytes/Macrophages. The FEBS Journal, 282, 1468-1480. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Eun, S., Lee, S., Xu, Y. and Croft, M. (2015) 4-1BB Ligand Signaling to T Cells Limits T Cell Activation. The Journal of Immunology, 194, 134-141. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Sheard, M.A., Krammer, P.H. and Zaloudik, J. (1999) Fractionated γ-Irradiation Renders Tumour Cells More Responsive to Apoptotic Signals through CD95. British Journal of Cancer, 80, 1689-1696. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Waring, P. and Müllbacher, A. (1999) Cell Death Induced by the Fas/Fas Ligand Pathway and Its Role in Pathology. Immunology & Cell Biology, 77, 312-317. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Kojima, S., Ishida, H., Takahashi, M. and Yamaoka, K. (2002) Elevation of Glutathione Induced by Low-Dose Gamma Rays and Its Involvement in Increased Natural Killer Activity. Radiation Research, 157, 275-280. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Cheda, A., Wrembel-Wargocka, J., Lisiak, E., Nowosielska, E.M., Marciniak, M. and Janiak, M.K. (2004) Single Low Doses of X Rays Inhibit the Development of Experimental Tumor Metastases and Trigger the Activities of NK Cells in Mice. Radiation Research, 161, 335-340. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Yang, G., Kong, Q., Wang, G., Jin, H., Zhou, L., Yu, D., et al. (2014) Low-Dose Ionizing Radiation Induces Direct Activation of Natural Killer Cells and Provides a Novel Approach for Adoptive Cellular Immunotherapy. Cancer Biotherapy and Radiopharmaceuticals, 29, 428-434. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Kojima, S., Nakayama, K. and Ishida, H. (2004) Low Dose γ-Rays Activate Immune Functions via Induction of Glutathione and Delay Tumor Growth. Journal of Radiation Research, 45, 33-39. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Sakaguchi, S. (2005) Naturally Arising Foxp3-Expressing CD25+CD4+ Regulatory T Cells in Immunological Tolerance to Self and Non-Self. Nature Immunology, 6, 345-352. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Valzasina, B., Piconese, S., Guiducci, C. and Colombo, M.P. (2006) Tumor-Induced Expansion of Regulatory T Cells by Conversion of CD4+CD25− Lymphocytes Is Thymus and Proliferation Independent. Cancer Research, 66, 4488-4495. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Kachikwu, E.L., Iwamoto, K.S., Liao, Y., DeMarco, J.J., Agazaryan, N., Economou, J.S., et al. (2011) Radiation Enhances Regulatory T Cell Representation. International Journal of Radiation Oncology Biology Physics, 81, 1128-1135. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Muroyama, Y., Nirschl, T.R., Kochel, C.M., Lopez-Bujanda, Z., Theodros, D., Mao, W., et al. (2017) Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment. Cancer Immunology Research, 5, 992-1004. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Liu, R., Xiong, S., Zhang, L. and Chu, Y. (2010) Enhancement of Antitumor Immunity by Low-Dose Total Body Irradiationis Associated with Selectively Decreasing the Proportion and Number of T Regulatorycells. Cellular & Molecular Immunology, 7, 157-162. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Wang, B., Li, B., Dai, Z., Ren, S., Bai, M., Wang, Z., et al. (2014) Low-Dose Splenic Radiation Inhibits Liver Tumor Development of Rats through Functional Changes in CD4+CD25+Treg Cells. The International Journal of Biochemistry & Cell Biology, 55, 98-108. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Chávez-Galán, L., Olleros, M.L., Vesin, D. and Garcia, I. (2015) Much More than M1 and M2 Macrophages, There Are Also CD169+ and TCR+ Macrophages. Frontiers in Immunology, 6, Article No. 263. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Sica, A. and Mantovani, A. (2012) Macrophage Plasticity and Polarization: In Vivo Veritas. Journal of Clinical Investigation, 122, 787-795. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Yang, D., Yang, L., Cai, J., Hu, X., Li, H., Zhang, X., et al. (2021) A Sweet Spot for Macrophages: Focusing on Polarization. Pharmacological Research, 167, Article ID: 105576. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Sica, A., Schioppa, T., Mantovani, A. and Allavena, P. (2006) Tumour-Associated Macrophages Are a Distinct M2 Polarised Population Promoting Tumour Progression: Potential Targets of Anti-Cancer Therapy. European Journal of Cancer, 42, 717-727. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Allavena, P., Sica, A., Garlanda, C. and Mantovani, A. (2008) The Yin‐Yang of Tumor‐Associated Macrophages in Neoplastic Progression and Immune Surveillance. Immunological Reviews, 222, 155-161. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
De Palma, M. and Lewis, C.E. (2013) Macrophage Regulation of Tumor Responses to Anticancer Therapies. Cancer Cell, 23, 277-286. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Prakash, H., Klug, F., Nadella, V., Mazumdar, V., Schmitz-Winnenthal, H. and Umansky, L. (2016) Low Doses of Gamma Irradiation Potentially Modifies Immunosuppressive Tumor Microenvironment by Retuning Tumor-Associated Macrophages: Lesson from Insulinoma. Carcinogenesis, 37, 301-313. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Nadella, V., Singh, S., Jain, A., Jain, M., Vasquez, K.M., Sharma, A., et al. (2018) Low Dose Radiation Primed iNOS+ M1macrophages Modulate Angiogenic Programming of Tumor Derived Endothelium. Molecular Carcinogenesis, 57, 1664-1671. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Klug, F., Prakash, H., Huber, P.E., Seibel, T., Bender, N., Halama, N., et al. (2013) Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype That Orchestrates Effective T Cell Immunotherapy. Cancer Cell, 24, 589-602. [Google Scholar] [CrossRef] [PubMed]
|
|
[65]
|
Hamzah, J., Jugold, M., Kiessling, F., Rigby, P., Manzur, M., Marti, H.H., et al. (2008) Vascular Normalization in Rgs5-Deficient Tumours Promotes Immune Destruction. Nature, 453, 410-414. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
Huang, Y., Kim, B.Y.S., Chan, C.K., Hahn, S.M., Weissman, I.L. and Jiang, W. (2018) Improving Immune-Vascular Crosstalk for Cancer Immunotherapy. Nature Reviews Immunology, 18, 195-203. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
Grabham, P., Hu, B., Sharma, P. and Geard, C. (2011) Effects of Ionizing Radiation on Three-Dimensional Human Vessel Models: Differential Effects According to Radiation Quality and Cellular Development. Radiation Research, 175, 21-28. [Google Scholar] [CrossRef] [PubMed]
|
|
[68]
|
Li, J., Zeng, Z., Wu, Q., Chen, J., Liu, X., Zhang, J., et al. (2021) Immunological Modulation of the Th1/Th2 Shift by Ionizing Radiation in Tumors (Review). International Journal of Oncology, 59, Article No. 50. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Yang, G., Li, W., Jiang, H., Liang, X., Zhao, Y., Yu, D., et al. (2016) Low‐Dose Radiation May Be a Novel Approach to Enhance the Effectiveness of Cancer Therapeutics. International Journal of Cancer, 139, 2157-2168. [Google Scholar] [CrossRef] [PubMed]
|
|
[70]
|
Sonanini, D., Griessinger, C.M., Schörg, B.F., Knopf, P., Dittmann, K., Röcken, M., et al. (2021) Low-Dose Total Body Irradiation Facilitates Antitumoral Th1 Immune Responses. Theranostics, 11, 7700-7714. [Google Scholar] [CrossRef] [PubMed]
|
|
[71]
|
Bent, R., Moll, L., Grabbe, S. and Bros, M. (2018) Interleukin-1 Beta—A Friend or Foe in Malignancies? International Journal of Molecular Sciences, 19, Article No. 2155. [Google Scholar] [CrossRef] [PubMed]
|
|
[72]
|
Lödermann, B., Wunderlich, R., Frey, S., Schorn, C., Stangl, S., Rödel, F., et al. (2012) Low Dose Ionising Radiation Leads to a NF-κB Dependent Decreased Secretion of Active IL-1β by Activated Macrophages with a Discontinuous Dose-Dependency. International Journal of Radiation Biology, 88, 727-734. [Google Scholar] [CrossRef] [PubMed]
|
|
[73]
|
Yu, N., Wang, S., Song, X., Gao, L., Li, W., Yu, H., et al. (2018) Low-Dose Radiation Promotes Dendritic Cell Migration and IL-12 Production via the ATM/NF-KappaB Pathway. Radiation Research, 189, 409-417. [Google Scholar] [CrossRef] [PubMed]
|
|
[74]
|
Schmidt, C.S. and Mescher, M.F. (2002) Peptide Antigen Priming of Naive, but Not Memory, CD8 T Cells Requires a Third Signal That Can Be Provided by IL-12. The Journal of Immunology, 168, 5521-5529. [Google Scholar] [CrossRef] [PubMed]
|
|
[75]
|
Frankenberger, B. and Schendel, D.J. (2012) Third Generation Dendritic Cell Vaccines for Tumor Immunotherapy. European Journal of Cell Biology, 91, 53-58. [Google Scholar] [CrossRef] [PubMed]
|
|
[76]
|
Xu, L., Zou, C., Zhang, S., Chu, T.S.M., Zhang, Y., Chen, W., et al. (2022) Reshaping the Systemic Tumor Immune Environment (STIE) and Tumor Immune Microenvironment (TIME) to Enhance Immunotherapy Efficacy in Solid Tumors. Journal of Hematology & Oncology, 15, 1-30. [Google Scholar] [CrossRef] [PubMed]
|
|
[77]
|
Casbon, A., Reynaud, D., Park, C., Khuc, E., Gan, D.D., Schepers, K., et al. (2015) Invasive Breast Cancer Reprograms Early Myeloid Differentiation in the Bone Marrow to Generate Immunosuppressive Neutrophils. Proceedings of the National Academy of Sciences, 112, E566-E575. [Google Scholar] [CrossRef] [PubMed]
|
|
[78]
|
McCoy, D.E., Feo, T., Harvey, T.A. and Prum, R.O. (2018) Structural Absorption by Barbule Microstructures of Super Black Bird of Paradise Feathers. Nature Communications, 9, Article No. 1. [Google Scholar] [CrossRef] [PubMed]
|
|
[79]
|
McAllister, S.S. and Weinberg, R.A. (2014) The Tumour-Induced Systemic Environment as a Critical Regulator of Cancer Progression and Metastasis. Nature Cell Biology, 16, 717-727. [Google Scholar] [CrossRef] [PubMed]
|
|
[80]
|
Yu, Y., Fu, P., Jin, J., Gao, S., Wang, W., Machtay, M., et al. (2021) Impact of Effective Dose to Immune Cells (EDIC) on Lymphocyte Nadir and Survival in Limited-Stage SCLC. Radiotherapy and Oncology, 162, 26-33. [Google Scholar] [CrossRef] [PubMed]
|
|
[81]
|
Xu, C., Jin, J., Zhang, M., Liu, A., Wang, J., Mohan, R., et al. (2020) The Impact of the Effective Dose to Immune Cells on Lymphopenia and Survival of Esophageal Cancer after Chemoradiotherapy. Radiotherapy and Oncology, 146, 180-186. [Google Scholar] [CrossRef] [PubMed]
|
|
[82]
|
Savage, T., Pandey, S. and Guha, C. (2020) Postablation Modulation after Single High-Dose Radiation Therapy Improves Tumor Control via Enhanced Immunomodulation. Clinical Cancer Research, 26, 910-921. [Google Scholar] [CrossRef] [PubMed]
|
|
[83]
|
Barsoumian, H.B., Sezen, D., Menon, H., Younes, A.I., Hu, Y., He, K., et al. (2022) High Plus Low Dose Radiation Strategy in Combination with TIGIT and PD1 Blockade to Promote Systemic Antitumor Responses. Cancers, 14, Article No. 221. [Google Scholar] [CrossRef] [PubMed]
|
|
[84]
|
Menon, H., Chen, D., Ramapriyan, R., Verma, V., Barsoumian, H.B., Cushman, T.R., et al. (2019) Influence of Low-Dose Radiation on Abscopal Responses in Patients Receiving High-Dose Radiation and Immunotherapy. Journal for ImmunoTherapy of Cancer, 7, Article No. 237. [Google Scholar] [CrossRef] [PubMed]
|
|
[85]
|
Patel, R.R., He, K., Barsoumian, H.B., Chang, J.Y., Tang, C., Verma, V., et al. (2021) High-Dose Irradiation in Combination with Non-Ablative Low-Dose Radiation to Treat Metastatic Disease after Progression on Immunotherapy: Results of a Phase II Trial. Radiotherapy and Oncology, 162, 60-67. [Google Scholar] [CrossRef] [PubMed]
|
|
[86]
|
Zhou, X., Zhou, L., Yao, Z., Huang, M., Gong, Y., Zou, B., et al. (2023) Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naïve Stage IV PD-L1+ Non-Small Cell Lung Cancer Patients. Clinical Cancer Research, 29, 4098-4108. [Google Scholar] [CrossRef] [PubMed]
|